$IBIO 8-K SEC Filings

Filed On	Filing
19 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year +1 more 1.He is the Chief Executive Officer and Chief Scientific Officer of iBio, Inc. (the “Corporation”), a Delaware corporation, and is duly authorized by the Board of Directors of the Corporation to execute this instrument.
13 Oct 2026	8-K: Regulation FD Disclosure; Other Events iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy
14 Sep 2026	8-K: Regulation FD Disclosure; Other Events BREAKTHROUGH ANTIBODIES FOR OBESITY AND CARDIOMETABOLIC DISEASES CORPORATE PRESENTATION • September 2026
28 Aug 2026	8-K: Results of Operations and Financial Condition
04 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
17 Jul 2026	8-K: Shareholder Director Nominations; Other Events
01 Jul 2026	8-K: Regulation FD Disclosure; Other Events
12 May 2026	8-K: Results of Operations and Financial Condition
08 May 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
08 Apr 2026	8-K: Regulation FD Disclosure; Other Events
09 Mar 2026	8-K: Regulation FD Disclosure; Other Events
27 Feb 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement
10 Feb 2026	8-K: Results of Operations and Financial Condition
12 Jan 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
21 Nov 2025	8-K: Submission of Matters to a Vote of Security Holders
17 Nov 2025	8-K: Regulation FD Disclosure; Other Events
12 Nov 2025	8-K: Results of Operations and Financial Condition
04 Nov 2025	8-K: Other Events
30 Oct 2025	8-K: Regulation FD Disclosure; Other Events
05 Sep 2025	8-K: Results of Operations and Financial Condition

Comments